What Happened:
Shares of health and wellness products company USANA Health Sciences (NYSE:USNA) jumped 11.5% in the morning session after the company reported first-quarter results with revenue narrowly exceeding Wall Street's expectations, though EPS beat by a more convincing amount. The topline benefitted from sales incentives in mainland China, which drove active customer growth. However, the company noted that other key markets did not meet internal expectations. In addition, its gross margin and full-year revenue guidance were underwhelming. Overall, this quarter's results were mixed.
Is now the time to buy USANA? Access our full analysis report here, it's free.
What is the market telling us:
USANA's shares are not very volatile than the market average and over the last year have had only 3 moves greater than 5%. Moves this big are very rare for USANA and that is indicating to us that this news had a significant impact on the market's perception of the business.
USANA is down 15.4% since the beginning of the year, and at $45.96 per share it is trading 32.3% below its 52-week high of $67.92 from July 2023. Investors who bought $1,000 worth of USANA's shares 5 years ago would now be looking at an investment worth $504.16.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefitting from the rise of AI, available to you FREE via this link.